Invesco Ltd. Bio Atla, Inc. Transaction History

Invesco Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.88 - $3.46 $1,434 - $2,639	-763 Reduced 3.61%	20,376 $70,000
Q4 2023 Feb 12, 2024	BUY	$1.27 - $3.18 $4,168 - $10,436	3,282 Added 18.38%	21,139 $52,000
Q3 2023 Nov 13, 2023	BUY	$1.7 - $3.07 $90 - $162	53 Added 0.3%	17,857 $30,000
Q2 2023 Aug 11, 2023	BUY	$2.83 - $3.87 $50,385 - $68,901	17,804 New	17,804 $53,000

17.3M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $62.4M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.